Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q3 2024 (September 30)10holders
$8.73avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings. The largest holders were Federation des caisses Desjardins du Quebec ($35K), Rhumbline Advisers ($9K) and Osaic Holdings, Inc. ($3K).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $49K |
| Exits | 0 | $0 |
Ownership 10 holders
| Federation des caisses Desjardins du Quebec | 0.00% | New | 3,992 | $35K |
| Rhumbline Advisers | 0.00% | New | 979 | $9K |
| Osaic Holdings, Inc. | 0.00% | New | 396 | $3K |
| Morgan Stanley | 0.00% | New | 180 | $2K |
| Group One Trading LLC | 0.00% | New | 22 | $192 |
| Earned Wealth Advisors, LLC | 0.00% | New | 5 | $44 |
| UBS Group AG | 0.00% | New | 3 | $26 |
| Bank of America Corp. | 0.00% | New | 2 | $17 |
| Danske Bank A/S | 0.00% | New | 2 | $17 |
| Royal Bank of Canada | 0.00% | New | 3 | $0 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.